Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease

被引：0
|
作者：
Tang, Mengyao [1 ,2 ]
Morieri, Mario Luca [3 ]
Kalim, Sahir [1 ,2 ]
Doria, Alessandro [2 ,4 ]
机构：
[1] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA USA
[2] Harvard Med Sch, Dept Med, Boston, MA USA
[3] Univ Padua, Dept Med, Padua, Italy
[4] Joslin Diabet Ctr, Res Div, Boston, MA 02215 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2025年
关键词：
diabetic kidney disease;
D O I：
10.1681/ASN.0000000620
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] A New Hope on the Horizon for Kidney and Cardiovascular Protection with SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Mineralocorticoid Receptor Antagonists in Type 2 Diabetic and Chronic Kidney Disease Patients
    Spasovski, Goce
    Rroji, Merita
    Hristov, Goce
    Bushljetikj, Oliver
    Spahia, Nereida
    Bushletikj, Irena Rambabova
    METABOLIC SYNDROME AND RELATED DISORDERS, 2024, 22 (03) : 170 - 178
  • [22] Diabetes and kidney disease: emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonists
    Prattichizzo, Francesco
    Candia, Paola de
    Ceriello, Antonio
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 120
  • [23] Prescription Patterns for GLP-1 Receptor Agonists and SGLT2 Inhibitors by Physicians' Years in Practice
    Inoue, Kosuke
    Kazi, Dhruv S.
    Vaduganathan, Muthiah
    Wadhera, Rishi K.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2025,
  • [24] Should We Be Combining GLP-1 Receptor Agonists and SGLT2 Inhibitors in Treating Diabetes?
    Packer, Milton
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (05): : 461 - 463
  • [25] GLP-1 receptor agonists and SGLT2 inhibitors: new anti-aging tools?
    Santulli, Gaetano
    Mone, Pasquale
    Varzideh, Fahimeh
    FUTURE CARDIOLOGY, 2025, 21 (01) : 5 - 8
  • [26] Comparative effectiveness of GLP-1 receptor agonists versus SGLT2 inhibitors in patients with type 2 diabetes and moderate chronic kidney disease
    Rossing, P.
    Fioretto, P.
    Clark, A.
    Jensen, A. B.
    Nazal, N. Belmar
    Tuttle, K. R.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S356 - S357
  • [27] SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease
    Honghong Zou
    Baoqin Zhou
    Gaosi Xu
    Cardiovascular Diabetology, 16
  • [28] SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease
    Zou, Honghong
    Zhou, Baoqin
    Xu, Gaosi
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [29] SGLT2 inhibitors vs. GLP-1 agonists: Comparative progression of renal disease
    Stevens, Lauren
    Bowe, Andy
    Schwab, Phil
    Tindal, Michael
    Bloomfield, Andrea
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 110 - 110
  • [30] Comparative Effectiveness of SGLT2 Inhibitors vs. GLP-1 Agonists
    Poonawalla, Insiya
    Bowe, Andy
    Tindal, Michael
    Meah, Yunus A.
    Schwab, Phil
    DIABETES, 2020, 69
12345